PKR Inhibitor (Synonyms: C16,GW 506033X,Protein Kinase RNA-activated) |
Catalog No.GC17925 |
El inhibidor de PKR (compuesto C16) es un inhibidor especÍfico de la proteÍna quinasa (PKR) dependiente de ARN de doble cadena.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 608512-97-6
Sample solution is provided at 25 µL, 10mM.
The activity of double-stranded RNA-activated protein kinase (PKR) is altered by viral infection as well as by various neuropathologies.[1],[2] A primary phosphorylation target of PKR is eukaryotic initiation factor 2 subunit α (eIF2α), blocking translation and driving apoptosis.3 PKR Inhibitor is an oxindole/imidazole derivative that binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.[3] PKR Inhibitor protects human neuroblastoma cells against cell damage triggered by tunicamycin-mediated endoplasmic reticulum stress.[4] It also prevents phosphorylation of Fas-associated protein with a death domain (FADD) in neuroblastoma cells, preventing FADD-dependent activation of caspases and apoptosis.[1] Intraperitoneal administration of PKR inhibitor in rats reduces phosphorylation of PKR and eIF2α in the brain.[5] Similar administration in mice enhances long-term memory storage, including contextual and auditory long-term fear memories.[2]
Reference:
[1]. Couturier, J., Morel, M., Pontcharraud, R., et al. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid β (Aβ)-treated cells and in APPSLPS1 knock-in mice. J. Biol. Chem. 285(2), 1272-1282 (2010).
[2]. Zhu, P.J., Huang, W., Kalikulov, D., et al. Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell 147(6), 1384-1396 (2011).
[3]. Jammi, N.V., Whitby, L.R., and Beal, P.A. Small molecule inhibitors of the RNA-dependent protein kinase. Biochemical and Biophysical Research Communications 308(1), 50-57 (2003).
[4]. Shimazawa, M., and Hara, H. Inhibitor of double stranded RNA-dependent protein kinase protects against cell damage induced by ER stress. Neuroscience Letters 409(3), 192-195 (2006).
[5]. Ingrand, S., Barrier, L., Lafay-Chebassier, C., et al. The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation. FEBS Letters 581(23), 4473-4478 (2007).
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *